Mucothiol «χωρίσ Ζάχαρη» (Carbocisteine)

Carbocisteine reduces mucus viscosity by breaking disulfide bonds within mucopolysaccharide fibers. This disruption weakens the polymer network of mucus, decreasing its elasticity and allowing the ciliary action of the respiratory tract to transport and expel secretions more efficiently.

The dosage of carbocisteine is individualized by the prescribing clinician based on the patient’s age, disease severity and renal function. No fixed regimen is provided here; the prescriber determines the appropriate strength and frequency.

Safety data for carbocisteine in pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Mucothiol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Carbocisteine differs from agents such as N‑acetylcysteine by primarily targeting disulfide bonds in mucopolysaccharides, whereas N‑acetylcysteine also acts as a free‑radical scavenger. Both thin mucus, but carbocisteine may have a more favorable taste profile and lower incidence of bronchospasm in some patients.

Store Mucothiol at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Mucothiol is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions given by their healthcare provider to optimise absorption and effectiveness.

Serious adverse events, although rare, include allergic reactions such as rash, urticaria or angioedema, as well as hepatic dysfunction indicated by elevated liver enzymes and hematologic effects like neutropenia. Immediate medical attention is required if any of these occur.

Carbocisteine should be avoided in patients with known hypersensitivity to the drug or any of its excipients. Caution is also advised for individuals with severe renal impairment, uncontrolled asthma or those taking multiple mucolytic agents without medical supervision.